Cardiol Therapeutics | WebDisclosure

Basculer en Français

10058	Companies
205602	Keywords
135838	Articles
109006	Press releases

Home
Companies
Cardiol Therapeutics

PRESS RELEASE

published on 06/14/2024 at 14:52, 1 year 9 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research increases Cardiol Therapeutics Inc's price target to USD8.50 in Buy recommendation after positive results from phase II trial of CardiolRx for recurrent pericarditis treatment

Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Phase II Trial CardiolRx
PRESS RELEASE

published on 02/27/2024 at 14:16, 2 years ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates BUY recommendation on Cardiol Therapeutics Inc. FDA grants Orphan Drug Designation for CardiolRx in pericarditis treatment. Positive phase II study results expected in Q2 2024

FDA Cardiol Therapeutics Inc First Berlin Equity Research Orphan Drug Designation Pericarditis
BRIEF

published on 02/27/2024 at 14:16, 2 years ago

Cardiol Therapeutics Receives FDA Orphan Drug Designation for CardiolRx

FDA Investment Orphan Drug Designation Cardiol Therapeutics Pericarditis
BRIEF

published on 02/27/2024 at 14:16, 2 years ago

Cardiol Therapeutics obtient la désignation de médicament orphelin par la FDA pour CardiolRx

Investissement FDA Orphan Drug Designation Cardiol Therapeutics Pericardite
PRESS RELEASE

published on 01/19/2024 at 12:41, 2 years 2 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research has published an update on Cardiol Therapeutics Inc., reaffirming its BUY recommendation and maintaining the price target of USD 3.60. The report highlights the progress in patient recruitment for CardiolRx's two lead indications, acute myocarditis (AM) and recurrent pericarditis (RP), with expectations of significant near-term catalysts for the stock. Analyst Christian Orquera remains optimistic about the company's investment potential. For the full analysis, visit the link provided.

Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Patient Recruitment Investment Potential
PRESS RELEASE

published on 08/30/2023 at 15:06, 2 years 6 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 05/24/2023 at 13:01, 2 years 9 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 04/11/2023 at 15:26, 2 years 11 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy

Accesswire

Published on 03/20/2026 at 23:00, 1 day 8 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 1 day 9 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 1 day 10 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 1 day 17 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 1 day 18 hours ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE

EQS Group

Published on 03/20/2026 at 22:45, 1 day 8 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 10 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 10 hours ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 10 hours ago

BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 1 day 11 hours ago

INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action

Les Echos

Published on 03/20/2026 at 19:00, 1 day 12 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 12 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 13 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 13 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 1 day 13 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE